PRRT2 and type 2 diabetes mellitus: In obese animal models, metformin reduced fibrosis, while in T2DM rats, it inhibited the PKC/ERK signaling pathway and preserved the expression of small-conductance calcium-activated potassium (SK) channels, whose downregulation is associated with AF [46,47].